Literature DB >> 8701077

Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development.

M M Matzuk1, T R Kumar, W Shou, K A Coerver, A L Lau, R R Behringer, M J Finegold.   

Abstract

With the advent of gene targeting in pluripotent mouse embryonic stem cells, it is now possible to modify the mammalian genome to generate mutant strains of mice with precise genetic mutations. The major goal of my laboratory is to generate transgenic mice to use as physiologic models to study mammalian reproduction and development. The initial focus of our research has been to generate mice deficient in inhibins, activins, activin binding proteins (i.e., follistatin), and activin receptors (i.e., activin receptor type II) to understand their interactions and roles in the hypothalamic-pituitary-gonadal axis and mammalian development. Inhibins and activins, dimeric members of the TGF-beta superfamily, were discovered due to their role in pituitary follicle stimulating hormone homeostasis. However, these proteins have later been shown to have diverse endocrine, paracrine, and autocrine functions. Activins have been shown to mediate their signals through type I and type II serine/threonine kinase receptors. The high interspecies conservation of activins, inhibins, and activin receptors and the universal presence of activins in mammals, birds, amphibians, and fish suggest an evolutionarily conserved role of these proteins in animal development. Our initial studies have demonstrated a tumor suppressor role of inhibin in the gonads and adrenals and have also suggested a role of activins in cancer cachexia-like syndrome. To further study the gonadal tumor development and the cancer cachexia-like syndrome in these mice, we have begun to generate mice with multiple genetic alterations (e.g., mice deficient in both inhibin and Mullerian inhibiting substance). We have also generated mice deficient in other components of this complex system (e.g., activin beta A, activin receptor type II, follistatin). Analysis of these transgenic mutant models has aided our overall understanding of the critical roles these proteins play in the development of the reproductive system, in the modulation of the endocrine milieu that regulates reproductive function, and in mammalian development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8701077

Source DB:  PubMed          Journal:  Recent Prog Horm Res        ISSN: 0079-9963


  26 in total

1.  Activin A binds to perlecan through its pro-region that has heparin/heparan sulfate binding activity.

Authors:  Shaoliang Li; Chisei Shimono; Naoko Norioka; Itsuko Nakano; Tetsuo Okubo; Yoshiko Yagi; Maria Hayashi; Yuya Sato; Hitomi Fujisaki; Shunji Hattori; Nobuo Sugiura; Koji Kimata; Kiyotoshi Sekiguchi
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

2.  Loss of inhibin alpha uncouples oocyte-granulosa cell dynamics and disrupts postnatal folliculogenesis.

Authors:  Michelle Myers; Brooke S Middlebrook; Martin M Matzuk; Stephanie A Pangas
Journal:  Dev Biol       Date:  2009-08-08       Impact factor: 3.582

Review 3.  The mammalian ovary from genesis to revelation.

Authors:  Mark A Edson; Ankur K Nagaraja; Martin M Matzuk
Journal:  Endocr Rev       Date:  2009-09-23       Impact factor: 19.871

4.  Retinoblastoma protein plays multiple essential roles in the terminal differentiation of Sertoli cells.

Authors:  Roopa L Nalam; Claudia Andreu-Vieyra; Robert E Braun; Haruhiko Akiyama; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2009-10-09

5.  Smad4 overexpression causes germ cell ablation and leydig cell hyperplasia in transgenic mice.

Authors:  Anita Narula; Signe Kilen; Eva Ma; Jessica Kroeger; Erwin Goldberg; Teresa K Woodruff
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

6.  Cripto forms a complex with activin and type II activin receptors and can block activin signaling.

Authors:  Peter C Gray; Craig A Harrison; Wylie Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

Review 7.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

Review 8.  The ovary: basic biology and clinical implications.

Authors:  Joanne S Richards; Stephanie A Pangas
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

9.  FOXO1/3 depletion in granulosa cells alters follicle growth, death and regulation of pituitary FSH.

Authors:  Zhilin Liu; Diego H Castrillon; Wei Zhou; Joanne S Richards
Journal:  Mol Endocrinol       Date:  2013-01-15

10.  Follicular expression of c-Kit/SCF and inhibin-alpha in mouse ovary during development.

Authors:  Jae Seong Kang; Chang Joo Lee; Jong Min Lee; Joong Yeol Rha; Kang Won Song; Moon Hyang Park
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.